These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 350230

  • 1. Chemotherapeutically active nitro compounds. 4.5-Nitroimidazoles (Part II).
    Winkelmann E, Raether W, Sinharay A.
    Arzneimittelforschung; 1978; 28(3):351-66. PubMed ID: 350230
    [Abstract] [Full Text] [Related]

  • 2. Chemotherapeutically active nitro compounds. 4. 5-Nitroimidazoles (Part I).
    Winkelmann E, Raether W, Gebert U, Sinharay A.
    Arzneimittelforschung; 1977; 27(12):2251-63. PubMed ID: 203293
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chemotherapeutically active nitro-derivatives. 4. 5-Nitroimidazoles (Part IV).
    Winkelmann E, Raether W, Gebert U.
    Arzneimittelforschung; 1978; 28(10):1682-4. PubMed ID: 582669
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chemotherapeutically active anthraquinones. II. Aminomethylanthraquinones.
    Winkelmann E, Raether W.
    Arzneimittelforschung; 1986 Feb; 36(2):234-47. PubMed ID: 3964330
    [Abstract] [Full Text] [Related]

  • 7. [Chemotherapeutic effects of nitro compounds. 1. Nitroanilines].
    Winkelmann VE, Raether W, Dittmar W, Düwel D, Gericke D, Hohorst W, Rolly H, Schrinner W, Wagner WH.
    Arzneimittelforschung; 1975 May; 25(5):681-708. PubMed ID: 1242309
    [Abstract] [Full Text] [Related]

  • 8. 1,4-Bis-[1-methyl-5-nitroimidazolyl-(2-methyleneimino)]-piperazine, a new drug with marked activity against Entamoeba histolytica. Short communication.
    Raether W, Seidenath H, Winkelmann E.
    Arzneimittelforschung; 1977 May; 27(5):968-9. PubMed ID: 195590
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nitroimidazoles, Part XXIII--activity of satranidazole series against anaerobic infections.
    Nagarajan K, Gowrishankar R, Arya VP, George T, Nair MD, Shenoy SJ, Sudarsanam V.
    Indian J Exp Biol; 1992 Mar; 30(3):193-200. PubMed ID: 1512026
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings.
    Grunberg E, Titsworth EH.
    Annu Rev Microbiol; 1973 Mar; 27():317-46. PubMed ID: 4584690
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tinidazole v. metronidazole.
    Drug Ther Bull; 1983 Nov 18; 21(23):90-2. PubMed ID: 6641520
    [No Abstract] [Full Text] [Related]

  • 16. Novel nitroimidazoles with trypanocidal and cell growth inhibition activities.
    Boechat N, Carvalho AS, Fernandez-Ferreira E, Soares RO, Souza AS, Gibaldi D, Bozza M, Pinto AC.
    Cytobios; 2001 Nov 18; 105(409):83-90. PubMed ID: 11393774
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nitroimidazoles: in vitro activity and efficacy in anaerobic infections.
    Tally FP, Goldin B, Sullivan NE.
    Scand J Infect Dis Suppl; 1981 Nov 18; 26():46-53. PubMed ID: 6941456
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.